Cargando…
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and direct factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in the prevention of embolic stroke in non-valvular atrial fibrillation as well as in the prevention and treatment of v...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360636/ https://www.ncbi.nlm.nih.gov/pubmed/28373761 http://dx.doi.org/10.3748/wjg.v23.i11.1954 |